JP2024517183A5 - - Google Patents

Info

Publication number
JP2024517183A5
JP2024517183A5 JP2023566673A JP2023566673A JP2024517183A5 JP 2024517183 A5 JP2024517183 A5 JP 2024517183A5 JP 2023566673 A JP2023566673 A JP 2023566673A JP 2023566673 A JP2023566673 A JP 2023566673A JP 2024517183 A5 JP2024517183 A5 JP 2024517183A5
Authority
JP
Japan
Prior art keywords
optionally substituted
formula
compound
pharmaceutically acceptable
isotope
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2023566673A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024517183A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/026268 external-priority patent/WO2022232088A1/en
Publication of JP2024517183A publication Critical patent/JP2024517183A/ja
Publication of JP2024517183A5 publication Critical patent/JP2024517183A5/ja
Withdrawn legal-status Critical Current

Links

JP2023566673A 2021-04-27 2022-04-26 転写増強アソシエートドメイン（ｔｅａｄ）転写因子阻害剤及びその使用 Withdrawn JP2024517183A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202163180418P 2021-04-27 2021-04-27
US63/180,418 2021-04-27
US202163291845P 2021-12-20 2021-12-20
US63/291,845 2021-12-20
PCT/US2022/026268 WO2022232088A1 (en) 2021-04-27 2022-04-26 Transcriptional enhanced associated domain (tead) transcription factor inhibitors and uses thereof

Publications (2)

Publication Number Publication Date
JP2024517183A JP2024517183A (ja) 2024-04-19
JP2024517183A5 true JP2024517183A5 (cg-RX-API-DMAC7.html) 2025-05-12

Family

ID=81750705

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023566673A Withdrawn JP2024517183A (ja) 2021-04-27 2022-04-26 転写増強アソシエートドメイン（ｔｅａｄ）転写因子阻害剤及びその使用

Country Status (6)

Country Link
US (1) US20240360104A1 (cg-RX-API-DMAC7.html)
EP (1) EP4330253A1 (cg-RX-API-DMAC7.html)
JP (1) JP2024517183A (cg-RX-API-DMAC7.html)
AU (1) AU2022266764A1 (cg-RX-API-DMAC7.html)
CA (1) CA3216260A1 (cg-RX-API-DMAC7.html)
WO (1) WO2022232088A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN119968359A (zh) 2022-09-29 2025-05-09 英矽智能科技知识产权有限公司 Tead抑制剂及其使用方法
IT202300026622A1 (it) * 2023-12-13 2025-06-13 Univ Degli Studi Di Modena E Reggio Emilia Composti ad attività antitumorale diretti alla hippo pathway

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX354412B (es) * 2011-06-10 2018-03-05 Merck Patent Gmbh Composiciones y metodos para la produccion de compuestos de pirimidina con actividad inhibidora de tirosina cinasa de bruton.
EP3866798A4 (en) * 2018-10-15 2022-07-13 Dana-Farber Cancer Institute, Inc. ENHANCED TRANSCRIPTIONAL ASSOCIATED DOMAIN (TEAD) TRANSCRIPTION FACTOR INHIBITORS AND THEIR USES

Similar Documents

Publication Publication Date Title
JP2022529700A5 (cg-RX-API-DMAC7.html)
JP2020509022A5 (cg-RX-API-DMAC7.html)
JP2023530231A5 (cg-RX-API-DMAC7.html)
ES2881776T3 (es) Compuestos tricíclicos útiles para tratar las infecciones por ortomixovirus
JP2019527682A5 (cg-RX-API-DMAC7.html)
JP2018515434A5 (cg-RX-API-DMAC7.html)
JP2024166311A (ja) 化合物、組成物、及び、方法
JP2024517183A5 (cg-RX-API-DMAC7.html)
JP5008778B2 (ja) 新規５−フルオロウラシル誘導体
JP2017502006A5 (cg-RX-API-DMAC7.html)
JP2008514610A5 (cg-RX-API-DMAC7.html)
JP2017520612A (ja) 抗がん剤としての官能化され置換されたインドール
AU2022317677B2 (en) Benzo [b] selenophene sting regulating agent, preparation method therefor and application thereof
WO2019012172A1 (es) Nuevos derivados heteroaryl amida como inhibidores selectivos de histona deacetilasa 1 y 2 (hdac1/2)
WO2018075959A4 (en) Methods using hdac11 inhibitors
JP2017517555A (ja) 阻害剤ｐ５３−Ｍｄｍ２タンパク質−タンパク質相互作用としての、１，１’，２，５’−テトラヒドロスピロ［インドール−３，２’−ピロール］−２，５’−ジオン系を含む化合物
US20250361218A1 (en) Agents and methods for treating dysproliferative diseases
CA3114637A1 (en) Derivative of sarsasapogenin, pharmaceutical composition and use thereof
JP2018507230A5 (cg-RX-API-DMAC7.html)
CN109790145A (zh) 二氢嘧啶类化合物及其制备方法和用途
JP2020516616A5 (cg-RX-API-DMAC7.html)
JP2024511389A5 (cg-RX-API-DMAC7.html)
JP2019510801A5 (cg-RX-API-DMAC7.html)
JP2024534420A5 (cg-RX-API-DMAC7.html)
JP7531506B2 (ja) アクリル含有核輸送モジュレーターおよびその使用